TITLE

Perindopril 2mg/Indapamide 0.625mg: Fixed Low-Dose Combination

AUTHOR(S)
McClellan, K.J.; Markham, A.
PUB. DATE
August 1999
SOURCE
Drugs;Aug1999, Vol. 58 Issue 2, p297
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
▴ Low-dose drug combinations have been proposed in International Guidelines for use in patients with hypertension. The fixed low-dose combination of perindopril 2mg with indapamide 0.625mg combines an angiotensin converting enzyme (ACE) inhibitor with a non-thiazide diuretic. ▴ Coadministration of perindopril and indapamide did not have any clinically significant effects on the pharmacokinetic profile of either agent in healthy volunteers. ▴ In experimental models of hypertension, perindopril/indapamide restored endothelial function, improved microvascular density, reduced left ventricular and aortic hypertrophy, and reversed renal end-organ damage. ▴ Once daily oral perindopril 2mg/indapamide 0.625mg normalised blood pressure (BP) in 83.6% of elderly patients with essential hypertension (diastolic BP was reduced to ≤90mm Hg) and 81.7% of those with isolated systolic hypertension (systolic BP was reduced to <160mm Hg) after ≈1 year of treatment. BP normalisation was sustained in 79.8% of patients throughout the study. ▴ Fixed low-dose perindopril/indapamide had a tolerability profile similar to that of placebo in clinical trials; most adverse events were of mild to moderate severity. Coadministration of the 2 agents reduced the incidence of hypokalaemia seen with indapamide alone.
ACCESSION #
9592861

 

Related Articles

  • The 2014 hypertension guidelines: Processing the information. Gelatic, Randee // JAAPA: Journal of the American Academy of Physician Assistants (;Nov2014, Vol. 27 Issue 11, p15 

    Recent guidelines on hypertension management offer conflicting recommendations. This article describes the JNC 8 and ASH/ISH guidelines and the four medications recommended for controlling BP in various patient populations.

  • Managing hypertension in patients with chronic kidney disease. Logan, I. R.; Tomson, C. R. V. // British Journal of Hospital Medicine (17508460);Nov2016, Vol. 77 Issue 11, p639 

    The article discusses the general principles to the investigation and treatment of hypertension in patients with chronic kidney disease, and offers a guide to situations that warrant specialty referral.

  • Combination Therapy in Hypertension: What Are the Best Options According to Clinical Pharmacology Principles and Controlled Clinical Trial Evidence? Taddei, Stefano // American Journal of Cardiovascular Drugs;Jun2015, Vol. 15 Issue 3, p185 

    Despite extensive debate about the first choice for treating essential hypertension, monotherapy effectively normalizes blood pressure (BP) values in only a limited number of hypertensive patients. Thus, the aim of combination therapy should always be to both improve BP control and to reduce...

  • Cocktail of hypertension drugs and NSAIDs linked to kidney problems.  // Practice Nurse;1/25/2013, Vol. 43 Issue 1, p10 

    The article discusses the results of a study which shows an increased risk of serious kidney problems for people who take triple combination of antihypertensive drugs and common painkillers. According to the study, 31 percent higher rate of kidney injury is associated with triple therapy...

  • Use of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of acute kidney injury. Townsend, Raymond R.; Cohen, Debbie L. // Evidence Based Medicine;Dec2013, Vol. 18 Issue 6, p232 

    The authors reflect on the study titled "Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study" by F. Lapi and colleagues published in a 2013...

  • Delapril plus Indapamide: A Review of the Combination in the Treatment of Hypertension. Cavalieri, Luca; Cremonesi, Giovanni // Clinical Drug Investigation;2007, Vol. 27 Issue 6, p367 

    Although many data indicate that the management of hypertension has improved over the last two decades, there is still a large proportion of hypertensive individuals who do not receive adequate management of their blood pressure (BP). Combination therapy with two or more antihypertensive agents...

  • Physicians must individualize hypertension treatment. Zablocki, Elaine // Managed Healthcare Executive;May2004, Vol. 14 Issue 5, p52 

    Reports on the need to individualize the treatment for hypertension. Different classes of drugs that control hypertension; Advantage of diuretics over calcium channel blocker, and angiotensin-converting enzyme (ACE) inhibitor; Efficacy of ACE inhibitors in hypertensive patients with left...

  • Fixed-Dose Combination Lercanidipine/Enalapril: A Viewpoint by Nicolás R. Robles. Robles, Nicolás R // Drugs;2007, Vol. 67 Issue 1, p107 

    â–´ Limaprost, an alprostadil (prostaglandin E1) analogue, is a vasodilator that increases blood flow and inhibits platelet aggregation.â–´ The efficacy of oral limaprost was evaluated in adult Japanese patients in three randomised, double-blind, 6-week trials. One study included...

  • Fixed-Dose Combination Lercanidipine/Enalapril: A Viewpoint by Roland Asmar. Asmar, Roland // Drugs;2007, Vol. 67 Issue 1, p107 

    â–´ Limaprost, an alprostadil (prostaglandin E1) analogue, is a vasodilator that increases blood flow and inhibits platelet aggregation.â–´ The efficacy of oral limaprost was evaluated in adult Japanese patients in three randomised, double-blind, 6-week trials. One study included...

  • Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases. Nadeem, Shahid; Batisky, Donald // Pediatric Nephrology;Nov2014, Vol. 29 Issue 11, p2105 

    This article provides a review of the role of aliskiren, a direct renin inhibitor, in pediatric hypertension and kidney diseases. Among the many mechanisms involved in regulating blood pressure, the renin-angiotensin-aldosterone system (RAAS) plays a major role. Additionally, the RAAS has been...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics